Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01193192 · ClinicalTrials.gov registry record
A Retrospective Analysis of Neevo® and NeevoDHA® Compared to a Standard Prenatal Vitamin in Anemia During Pregnancy
A clinical trial, sponsored by Pamlab, L.L.C..
- Terminated
- Registry status
- 30
- Enrollment target
NCT01193192 is a clinical trial that was terminated before completion, run by Pamlab, L.L.C.. The registered enrollment target is 30 participants.
The verdict
NCT01193192 was terminated before completion, sponsored by Pamlab, L.L.C..
- TERMINATED
- Registry status
- 30 participants
- Enrollment target
Study Summary
This study is a multi-site, retrospective chart review to determine the effect of Neevo® or NeevoDHA® (with higher folate and B12) versus standard prenatal vitamins on hemoglobin (Hgb) levels in pregnant women throughout the course of pregnancy. Neevo® is a prescription medical food indicated for the dietary management of women under a doctor's care who face high risk pregnancies, older overactive bladder (OB) patients and patients unable to fully metabolize folic acid. Data will be collected from existing patient charts of subjects administered Neevo® or NeevoDHA® daily compared to subjects administered a prenatal vitamin daily.
Interventions
- OTHER Neevo®
- OTHER Prenatal vitamins
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2010-07 |
| Est. Completion | 2010-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01193192
The ClinicalTrials.gov registry entry for NCT01193192 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pamlab, L.L.C., which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Neevo® is the first listed.
NCT01193192 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01193192 about?
NCT01193192 is a clinical study titled "A Retrospective Analysis of Neevo® and NeevoDHA® Compared to a Standard Prenatal Vitamin in Anemia During Pregnancy". This study is a multi-site, retrospective chart review to determine the effect of Neevo® or NeevoDHA® (with higher folate and B12) versus standard prenatal vitamins on hemoglobin (Hgb) levels in pregnant women throughout the course of pregnancy. Neevo® is a prescription medical food indicated for th...
What is the current status of trial NCT01193192?
This trial is currently terminated. The enrollment target is 30 participants. The study started on 2010-07. Estimated completion is 2010-11.
What interventions are being tested in trial NCT01193192?
The interventions under investigation include: Neevo® (OTHER), Prenatal vitamins (OTHER).
Who is sponsoring clinical trial NCT01193192?
This trial is sponsored by Pamlab, L.L.C., which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.